Ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-imidazole-5-carboxylate

We are Ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-imidazole-5-carboxylate CAS:144689-93-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: Ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-imidazole-5-carboxylate
CAS.NO: 144689-93-0
Synonyms: 
Ethyl 4-(2-Hydroxy-2-propyl)-2-propyl-1H-imidazole-5-carboxylate
4-(1-Hydroxy-1-methylethyl)-2-propyl
Ethyl 4-(1-hydroxy-1-methylethyl)-2-propylimidazole-5-carboxylate
4-(2-Hydroxy-2-propyl)-2-propyl-1H-imidazole-5-carboxylic Acid Ethyl Ester
4-(1-Hydroxy-1-methylethyl)-2-propyl-

Molecular Formula: C12H20N2O3
Molecular Weight:  240.29900

Physical and Chemical Properties:
Density: 1.131g / cm3
Boiling point: 456.2ºC at 760mmHg
Melting point: /
Flash point: 229.7ºC
Refractive index: 1.521

Specification:
Appearance:Pale yellow powder
Purity:≥98%
Residue on ignition:≤0.5%
Water:≤0.5%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Olmesartan CAS:144689-24-7
Intermediates of Olmesartan medoxomil  CAS:144689-63-4

Related News: The downstream industry of the pharmaceutical intermediate industry is mainly the production of APIs, and the relationship between APIs and preparations is in the upstream and downstream industry chain. The consumer demand for downstream preparations will directly affect the demand for APIs.Ácido (2S) -2-amino-3- (4-nitrofenil) propanoico, hidrato CAS:207591-86-4 The term active pharmaceutical ingredient may refer to an active chemical within an FDA-regulated drug, or API might mean the entire drug with its active and inactive ingredients.1427-07-2 Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality.D-Ornithine Monohydrochloride By drawing these distinctions between APIs and the drugs themselves, manufacturers are able to specialize and pharmacists able to align generic equivalents with brand names.By drawing these distinctions between APIs and the drugs themselves, manufacturers are able to specialize and pharmacists able to align generic equivalents with brand names.